Centre for Cardiovascular and Metabolic Neuroscience, UCL/WHRI, QMUL
London, England
Joined May 2017
- Tweets142
- Following145
- Followers173
- Likes98
CCMN retweeted
It’s been a fantastic week at @TheIUPS meeting in Frankfurt. Grateful for the opportunity to share our latest findings on the role of GIPR in vascular health—exciting insights ahead! #IUPS2025 #VascularBiology #GIPR #incretins
📣 New paper out exploring brain access of Tirzepatide based fluorescent analogues! We are proud to have contributed to this multi-lab effort.
Fluorescent GLP1R/GIPR dual agonist probes reveal cell targets in the pancreas and brain go.nature.com/3HFXptW
📣 Excited to share that members of the Adriaenssens lab are proud to have contributed to a new paper exploring GIPR signaling in oligodendrocytes. A great collaboration with the @blouetlab
New! Online now: Glucose-dependent insulinotropic polypeptide receptor signaling in oligodendrocytes increases the weight-loss action of GLP-1R agonism dlvr.it/TMSwJG
CCMN retweeted
@QMULWHRI @CCPMG_TEAM @CCMN_London Physiological Significance of Endothelial M3 Muscarinic Receptors During Exercise | Circulation Research ahajournals.org/doi/10.1161/…
Can targeting GLP-1 in the brain revolutionise obesity treatment? 🧠💉
Check out Professor Stefan Trapp’s take on how central GLP-1 pathways could transform the future of obesity care.
drugtargetreview.com/article…
📣 New publication alert!
“Redefining respiratory sinus arrhythmia as respiratory heart rate variability: an international Expert Recommendation for terminological clarity” is now out!
Read the full article here:
nature.com/articles/s41569-0…
CCMN retweeted
Unravelling the GIPR agonist versus antagonist paradox go.nature.com/3Gu8UDU
CCMN retweeted
From Ozempic to Wegovy, GLP-1 mimics are everywhere lately!
Join our free webinar, starting very soon, to learn the science behind them from the experts - attendee.gotowebinar.com/reg…
GLP-1 hormones are at the forefront of new treatments for metabolic disorders. Join leading experts as they discuss their potential and future applications tomorrow in a free webinar. Don't miss out: attendee.gotowebinar.com/reg…
📣Professor Stefan Trapp will be giving a talk as part of the webinar titled Harnessing Hormones for Health: Taking GLP-1 from Research to Reality hosted by @ChemistryWorld
Join to learn all about the groundbreaking science behind obesity drugs on March 6th at 3:00pm
CCMN retweeted
Can vagus nerve stimulation enhance exercise capacity? A new randomized trial explores the effects of non-invasive vagus nerve stimulation on exercise performance in healthy volunteers. Read more in #EHJ.
doi.org/10.1093/eurheartj/eh…
#vagusnerve #cardiotwitter @ESC_Journals @escardio
New study from @AcklandLab and CCMN! This randomized, double-blind, sham-controlled, crossover trial in healthy volunteers shows that vagal stimulation increases peak O₂ consumption and power output during exercise and has a strong anti-inflammatory effect.
CCMN retweeted
This beautiful study by @PippaWittenberg provides evidence that an intracranial baroreceptor mechanism regulates systemic arterial blood pressure to maintain cerebral perfusion."
My recent paper supporting evidence for the existence of an intracranial baroreceptor detecting and regulating cerebral blood flow 🧠🫀 Please give it a read!
physoc.onlinelibrary.wiley.c…
@JPhysiol
@TheBHF
CCMN retweeted
@CCMN_London continue to produce impactful physiology classics & the recent paper is no exception @uclnpp @uclnews
Congratulations @PippaWittenberg, @FionaMcbryde & all co-authors you have clearly been working hard.
physoc.onlinelibrary.wiley.c…
#CBF #brain #neuroscience
📣 @wanqing_jiang from the Trapp lab successfully defended her PhD thesis. Congratulations 🎓!!
📣 A new paper from the Gourine lab led by @PippaWittenberg, came out this week! Check it out to learn about the existence of an intracranial baroreceptor mechanism that regulates cerebral blood flow.
doi.org/10.1113/JP285082